Mexitil and Heart attack - a phase IV clinical study of FDA data

Summary:

Heart attack is reported as a side effect among people who take Mexitil (mexiletine hydrochloride), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Lasix, and have Bone disorder.

The phase IV clinical study analyzes which people have Heart attack when taking Mexitil. It is created by eHealthMe based on reports of 1,881 people who have side effects when taking Mexitil from the FDA, and is updated regularly.

What is Mexitil?

Mexitil has active ingredients of mexiletine hydrochloride. eHealthMe is studying from 1,893 Mexitil users. Check the latest studies of Mexitil.

What is Heart attack?

Heart attack is found to be associated with 2,485 drugs and 3,296 conditions by eHealthMe. Check the latest studies of Heart attack.

On Jul, 11, 2026

1,881 people reported to have side effects when taking Mexitil.
Among them, 37 people (1.97%) have Heart attack.

Among these 37 people:

How long have people been on Mexitil when they have Heart attack? *

What is the gender of people who have Heart attack when taking Mexitil? *

female: 18.92 %
male: 81.08 %

What is the age of people who have Heart attack when taking Mexitil? *

What are other drugs people take besides Mexitil? *

What are other side effects people have besides Heart attack? *

Mitral Valve Incompetence (inefficient heart valve): 21 people, 56.76%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 21 people, 56.76%
Injury: 20 people, 54.05%
Cardiac Failure Congestive: 20 people, 54.05%
Dyslipidaemia (abnormal amount of lipids): 19 people, 51.35%
Cardiomyopathy (weakening of the heart muscle): 19 people, 51.35%
Pain: 19 people, 51.35%
Dyspnea (difficult or laboured breathing): 19 people, 51.35%
Oedema Peripheral (superficial swelling): 19 people, 51.35%
Neuropathy Peripheral (surface nerve damage): 19 people, 51.35%

What are the existing conditions these people have? *

Bone Disorder: 18 people, 48.65%
Multiple Myeloma (cancer of the plasma cells): 10 people, 27.03%
High Blood Pressure: 3 people, 8.11%
Arrhythmias (irregular heartbeat): 2 people, 5.41%
Ventricular Extrasystoles (premature cardiac contraction): 1 person, 2.70%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 2.70%
Sick Sinus Syndrome (a collection of heart rhythm disorders): 1 person, 2.70%
Paroxysmal Nocturnal Haemoglobinuria (haemoglobin in the urine): 1 person, 2.70%
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 1 person, 2.70%
Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 1 person, 2.70%

* Approximation only. Some reports may have incomplete information.

Do you take Mexitil and have Heart attack?

- Check whether Heart attack is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mexitil:

Mexitil (1,893 reports)

Heart attack treatments and more:

Heart attack (266,145 reports)

Browse all side effects of Mexitil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Heart attack:

Heart attack (2,485 drugs)

Browse all the conditions that are associated with Heart attack:

Heart attack (3,296 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mexiletine hydrochloride (the active ingredients of Mexitil) and Mexitil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.